Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001363619 | SCV001559739 | uncertain significance | Carpenter syndrome | 2021-09-01 | criteria provided, single submitter | clinical testing | This sequence change disrupts the translational stop signal of the RAB23 mRNA. It is expected to extend the length of the RAB23 protein by 69 additional amino acid residues. This variant is present in population databases (rs751619487, ExAC 0.006%). This variant has not been reported in the literature in individuals affected with RAB23-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Institute of Human Genetics, |
RCV002287498 | SCV002577923 | likely pathogenic | See cases | 2021-12-08 | criteria provided, single submitter | clinical testing | ACMG categories: PS5,PM2,PM4,PP4 |
Natera, |
RCV001836364 | SCV002083433 | uncertain significance | RAB23-related Carpenter syndrome | 2017-06-26 | no assertion criteria provided | clinical testing |